The investment seeks to track the investment results of the Dow Jones U.S. Select Medical Equipment Index composed of U.S. equities in the medical devices sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index includes medical equipment companies such as manufacturers and distributors of medical devices such as magnetic resonance imaging (MRI) scanners, prosthetics, pacemakers, X-ray machines, and other non-disposable medical devices. The fund is non-diversified.
Inception Date: 01/05/2006
Primary Benchmark: DJ US Select Medical Equip TR USD
Primary Index: MSCI ACWI NR USD
Gross Expense Ratio: 0.44%
Management Expense Ratio: 0.43 %
|ABT||Abbott Laboratories||9.22 %|
|MDT||Medtronic plc.||8.84 %|
|TMO||Thermo Fisher Scientific Inc||7.17 %|
|DHR||Danaher Corporation||5.87 %|
|BDX||Becton Dickinson and Company||5.57 %|
|ISRG||Intuitive Surgical Inc.||5.16 %|
|BSX||Boston Scientific Corporation||4.83 %|
|SYK||Stryker Corporation||4.74 %|
|BAX||Baxter International Inc.||3.74 %|
|EW||Edwards Lifesciences Corporation||3.64 %|
|XLV||SPDR Select Sector Fund - Heal..||0.13 %||
|VHT||Vanguard Health Care||0.10 %||
|XBI||SPDR Series Trust S&P Biotech||0.35 %||
|FBT||First Trust Amex Biotech Index..||0.56 %||
|IYH||iShares U.S. Healthcare||0.43 %||
|FXH||First Trust Health Care AlphaD..||0.62 %||
|IXJ||iShares Global Healthcare||0.47 %||
|FHLC||Fidelity MSCI Health Care Inde..||0.08 %||
|IHF||iShares U.S. Health Care Provi..||0.43 %||
|HQH||Tekla Healthcare Investors||0.00 %||
|Market Performance vs.
|Market Performance vs. Exchange (NYSE Arca)|
|Value||Sector Median||Percentile Rank||Grade||Market Median||Percentile Rank||Grade|
|Trailing 12 Months|
|Trailing 5 Years|
|Average Annual (5 Year Horizon)|
|Risk Return Profile|
|Volatility (Standard Deviation)||8.47%||89%||B+||74%||C|
|Risk Adjusted Return||230.31%||100%||A+||99%||A+|
|Target Price Action||Rating Action||Analyst||Rating||Price||Date|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
The company has under performed its peers on annual average total returns in the past 5 years.